Companies: 10,795·Total market cap: $144.5T
Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

HOWLNASDAQHealthcare● Active
$0.37
$-0.01(-1.86%)
Market Cap$18214081
P/E Ratio—
52W High$2.38
52W Low$0.37
Overview

Werewolf Therapeutics, Inc. (HOWL) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · HOWL · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($0.06B)($0.07B)($0.04B)($0.05B)($0.05B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.01B$0.01B$0.01B$0.01B$0.00B
Change in Working Capital($0.01B)$0.00B($0.01B)$0.00B$0.00B
Net Cash from Operations($0.06B)($0.06B)($0.03B)($0.04B)($0.04B)
Investing Activities
Capital Expenditure$0.00B($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing$0.00B($0.00B)($0.00B)($0.00B)($0.00B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B($0.01B)$0.04B$0.00B$0.00B
Net Cash from Financing$0.01B$0.01B$0.06B$0.02B$0.11B
Free Cash Flow
Free Cash Flow($0.06B)($0.06B)($0.03B)($0.04B)($0.04B)
FCF Margin %(computed)——-167.38%-269.54%—

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

SEC 10-K filings →SEC 10-Q filings →

Explore more Werewolf Therapeutics, Inc. data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Werewolf Therapeutics, Inc. (HOWL) Cash Flow Statement

Werewolf Therapeutics, Inc. generated operating cash flow of ($0.06B) and free cash flow of ($0.06B) for 2025 — a FCF margin of —. Capital expenditure was $0.00B.

Frequently asked questions

HOWL · 4 questions

Werewolf Therapeutics, Inc. generated free cash flow of ($0.06B) for 2025, down 6.8% year-over-year.

HOWL free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10